Active · per the CBE, 2 October 2026

BELIPHARM

BE0884446592

Rechtspersoon Private limited company 1 establishment

BELIPHARM is a wholesaler in Leuven. Private Limited, started on 4 October 2006, 1 establishment.

Herestraat 13, 3000 Leuven

Behind the company: Ivo QUINTENS.

Active for

19 year, 11 months

Financials

Financial year 2025

BELIPHARM from Leuven, company number BE0884446592, closed financial year 2025 with a result of € 22,885 after tax. For that financial year BELIPHARM recorded a gross margin of € 36,326 and equity of € 35,863. Compared with financial year 2024, the result moved from € 22,240 to € 22,885. Profitable, and profit is growing. The buffer is growing. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 9, 2026.

What it is worth Growing

€ 35,863

▲ 176% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 22,885

▲ 3% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 7,988

▲ 3% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 29,663.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 292,439

▲ € 264,867 vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 15,657

▲ 272% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
2022202320242025Change 2024 → 2025
Gross margin € 25,046 € 47,343 € 28,038 € 36,326 ▲ 30%
Profit after taxes € 21,568 € 45,049 € 22,240 € 22,885 ▲ 3%
Equity € -54,311 € -9,262 € 12,978 € 35,863 ▲ 176%
Total debts € 76,100 € 155,360 € 129,532 € 413,922 ▲ 220%
Cash € 10,929 € 7,132 € 7,727 € 7,988 ▲ 3%
Retained profit € -60,511 € -15,462 € 6,778 € 29,663 ▲ € 22,885
Balance sheet total € 21,789 € 146,098 € 142,510 € 449,785 ▲ 216%

Key figures of BELIPHARM, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to BELIPHARM?

What happened at BELIPHARM in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: profit of € 22,885 (▲ 3% vs 2024). Source: NBB ↗
  • New establishment in Leuven. KBO
  • Start of the company according to the CBE. KBO

In short

From € 21,568 profit in 2022 to € 22,885 profit in 2025.

Paid € 15,707 in corporate taxes since 2022.

Best year ever: 2023, with € 45,049 profit.

Original PDFs at the National Bank ↗

A new publication or filing at BELIPHARM? We notify you, reason included.

Follow BELIPHARM

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

  1. Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
  2. We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
  3. In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Yes, I want that
See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies
  • De Lijn 8 June 2026 New annual account 2025

    filed on 8 June 2026

    What was left

    € 20 k ▼ 91%

    Money in the bank

    € 178 k ▼ 98%

    Open the dossier →

  • NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
  • bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Real filings at the National Bank

Management

Ivo QUINTENS
BELIPHARM

Behind BELIPHARM is Ivo QUINTENS.

See the full network in the app

Directors

According to the 2025 annual accounts

Ivo QUINTENS

Andere functie

Establishments

Establishment units

Physical locations of this company

Registered office

Herestraat 13

3000 Leuven

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number
0884.446.592
VAT number
BE 0884.446.592
Registered office
Herestraat 13, 3000 Leuven
Names & denominations
BELIPHARM
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
4 October 2006
Peppol
Active · Active since 6 Jan 2026
Activities · NACE

Groothandel in farmaceutische en medische artikelen

Groothandel in farmaceutische producten

Niet-gespecialiseerde groothandel

Groothandel in parfumerieën en cosmetica

Overige groothandel

View on CBE Public ↗ Annual accounts (NBB) ↗

Frequently asked questions

What does BELIPHARM do?
BELIPHARM is a wholesaler in Leuven. Private Limited, started on 4 October 2006, 1 establishment.
What is the address of BELIPHARM?
The registered office of BELIPHARM is located at Herestraat 13, 3000 Leuven.
Is BELIPHARM still active?
Yes. According to the CBE (2 October 2026) BELIPHARM is active, legal situation “Normale toestand”, started on 4 October 2006.
Is BELIPHARM registered on Peppol?
Yes, BELIPHARM is registered on the Peppol network with ID 0208:0884446592.
What is the enterprise number of BELIPHARM?
The enterprise number of BELIPHARM is BE0884446592.
When was BELIPHARM founded?
BELIPHARM was founded on 4 October 2006.